+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 100Years
All Genders
Healthy Volunteers
ID05634967

Observational Study on Pregnancy and Infant Outcomes in Women Treated with Kesimpta for Multiple Sclerosis

Led by Novartis Pharmaceuticals · Updated on 2025-01-14

725

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating pregnancy and infant outcomes in women with Multiple Sclerosis MS who are exposed to Kesimpta ofatumumab during pregnancy. This observational study aims to gather safety information on Kesimpta use in pregnancy by comparing outcomes among women exposed to Kesimpta, women with MS not exposed to Kesimpta, and healthy women without MS or autoimmune diseases. The study is sponsored by Novartis Pharmaceuticals and will collect data from two independent pregnancy registries in the USCanada and Germany. The study involves three groups pregnant women with MS treated with Kesimpta, pregnant women with MS not exposed to Kesimpta, and healthy pregnant women without MS or autoimmune diseases only in the USCanada registry. It is a non-interventional study where participants are observed and data are collected through interviews, medical record reviews, infant examinations, and developmental questionnaires. Both registries will gather data independently which will then be combined for analysis. Participants will be followed for up to 21 months, including pregnancy and infant outcomes. Assessments include tracking major structural defects, miscarriages, stillbirths, preterm deliveries, growth, infections in infants, and developmental milestones using validated questionnaires. Researchers will monitor pregnancy outcomes and infant health through interviews, medical records, and developmental tests. The study will continue for about 7 years to capture sufficient data on Kesimpta exposure during pregnancy.

CONDITIONS

Brief Title

Kesimpta (Ofatumumab) Pregnancy Registry

Research Team

N

Novartis Pharmaceuticals

N

Novartis Pharmaceuticals

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here